Loading...
NPI 1275774747 · Newark, DE · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Christiana Spine Ambulatory Surgical Center, LLC is a ambulatory surgical clinic/center provider located in Newark, Delaware. This profile covers 12 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Christiana Spine Ambulatory Surgical Center, LLC |
| Address | 1101 Twin C Lane |
| City | Newark |
| State | DE |
| ZIP | 19713 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | March 13, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.7M |
| Medicaid | $33.5K |
The provider’s Medicare billing is concentrated in interventional spine and pain procedures: the highest-revenue Medicare codes are 64483, 64635, and 64493, which represent common transforaminal epidural injections, neurolytic/denervation procedures, and facet joint injections under imaging guidance. These code choices are consistent with an ambulatory surgical center focused on spine pain management rather than broad multispecialty surgical services.
Medicare revenue is highly concentrated in a very small set of services: the top three Medicare codes (64483, 64635, 64493) together account for 75.2% of this provider’s total Medicare revenue, with code-level revenues of $947.9K (64483, 54.7%), $198.5K (64635, 11.5%), and $156.5K (64493, 9.0%). This concentration indicates the center’s financial performance depends largely on repeated, high-volume interventional pain procedures.
Medicaid activity is effectively single-code and very small in scale: total Medicaid revenue is $33.5K and 100.0% of that Medicaid revenue is from 64483 (189 claims, $177 avg paid/claim). In practice this means the provider’s Medicaid footprint is narrow and entirely driven by the same transforaminal epidural injection that dominates its Medicare business.
The payer mix is overwhelmingly Medicare-driven: lifetime Medicare revenue is $1.7M versus $33.5K in Medicaid, so Medicare is the dominant payer by a large margin and the practice operates as a Medicare-focused ambulatory spine/interventional center rather than a Medicaid-focused provider. Analysts should treat Medicaid volumes as a secondary signal when evaluating capacity and revenue risk.
The provider is a national outlier on several high-value Medicare codes, demonstrating concentrated competitive strength in those services. Notably, 64483 ranks #1 of 8202 providers nationally (100th percentile; extreme outlier), 64635 ranks #54 of 5957 (99th percentile; extreme outlier), and 64493 ranks #41 of 7519 (99th percentile; extreme outlier), indicating exceptionally high national volumes for targeted spine procedures.
By contrast, the provider’s standing in Medicaid for the same dominant code is modest within-state: Medicaid 64483 ranks #8 of 9 in-state (13th percentile; typical, unremarkable volume), which suggests strong Medicare-market positioning does not translate into statewide Medicaid dominance for this procedure. This divergence implies payer-specific referral patterns or contracting differences that limit Medicaid case capture.
The procedural mix includes occasional higher-cost implant or device procedures but at low frequency, which tempers the otherwise injection-heavy profile. For example, 63650 (epidural electrode placement) generated $68.1K from 19 Medicare claims and ranks #1343 of 1371 providers nationally (1th percentile; typical, unremarkable volume), indicating device/implant work is performed but is not a primary revenue driver.
The entity has an established operating history with sustained Medicare activity: the NPI was enumerated 2009-03-13 (~17 years ago). That tenure, combined with $1.7M in lifetime Medicare revenue and high national ranks on key spine-intervention codes, supports the conclusion that this is a stable, specialized ambulatory surgical center focused on spine/interventional pain services rather than a new or generalist facility.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 3,240 | $290 | $947.9K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 330 | $610 | $198.5K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 550 | $280 | $156.5K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 400 | $260 | $104.7K |
| 62321 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the cervical (neck) or thoracic (upper and middle back)… | 270 | $260 | $70K |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 20 | $3,580 | $68.1K |
| 64633 | In this procedure, the provider destroys the facet joint nerve of a cervical or thoracic spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 70 | $670 | $45.7K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 210 | $220 | $45.1K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 130 | $320 | $41.7K |
| 64479 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either cervical or thoracic). | 90 | $340 | $31.9K |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 190 | $180 | $33.5K |
How this provider's Medicaid billing volume and revenue compare to other Delaware providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Delaware median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 8 | 10 | 340 | $140 | $79.7K |
Other providers in the same ZIP code as Christiana Spine Ambulatory Surgical Center, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.